A detailed history of Benin Management Corp transactions in Repligen Corp stock. As of the latest transaction made, Benin Management Corp holds 5,000 shares of RGEN stock, worth $600,700. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,000 -0.0%
Holding current value
$600,700
Previous $899,000 2.22%
% of portfolio
0.29%
Previous 0.31%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 20, 2018

BUY
$35.26 - $47.04 $176,300 - $235,200
5,000 New
5,000 $235,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.67B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Benin Management Corp Portfolio

Follow Benin Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.